A simple PCR of mouth rinse may serve as a useful non-invasive test in diagnosing Pneumocystis pneumonia compared with ...

The ongoing hantavirus outbreak carries disturbing echoes of the early days of COVID: people falling ill on a cruise ship from a relatively unknown pathogen, with no validated test available to ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The U.S. Centers for Disease Control and Prevention (CDC) currently ...

A lab at the University of Nebraska has developed a test that can detect the virus before symptoms become severe. Now, it's ready to start testing cruise ship passengers returning to the US. As ...

The methods used to diagnose hantavirus and Covid-19 are very differentAI-generated image The recent hantavirus outbreak linked to the Dutch cruise ship MV Hondius has renewed public attention on how ...

As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...

Patients in rural communities often lack timely access to innovative infectious disease testing because diagnostic laboratories are located far away. Long transport times and logistical barriers delay ...

A new biotechnology company in McKinney has ambitions to become the world's first fully integrated platform for polymerase chain reaction (PCR) testing - the same technology behind a common COVID-19 ...

An expert panel convened by the nation’s top post-acute care medical organization has recommended against the routine use of urine PCR tests to diagnose urinary tract infections. Such tests have ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

Phase 1 trial of SHR-A2102, a nectin-4–directed antibody drug conjugate (ADC), in advanced solid tumors. Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A ...

PCR is a mainstay in diagnostics, but whether a sample is collected at a clinic or at home, such tests require sending a sample to a lab and then waiting for results. A new FDA authorized ...